Comparison of Single Intravitreal Injection of Triamcinolone or Bevacizumab for the Treatment of Diabetic Macular Edema
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare a single intravitreal injection of 4.0 mg of
triamcinolone acetonide and 1.25 mg of bevacizumab for the treatment of diabetic macular
edema.